Austrian enforcer settles predatory pricing probe into Merck

Austria's Federal Competition Authority has accepted commitments from pharmaceutical company Merck Sharp & Dohme's local subsidiary to stop charging predatory prices for a brain tumour drug.


Get unlimited access to all Global Competition Review content